Ungerleider R M
Division of Thoracic Surgery and Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA.
Ann Thorac Surg. 1998 Jun;65(6 Suppl):S35-8; discussion S39, S74-6. doi: 10.1016/s0003-4975(98)00327-0.
Hemodilution is a prominent problem in cardiopulmonary bypass in a pediatric population. Ultrafiltration is a method used to reduce fluid volume and tissue edema and to increase hematocrit without the need for blood products. Modified ultrafiltration may offer advantages in comparison with conventional ultrafiltration.
This article reviews the technique of modified ultrafiltration and its use, results, complications, and safety in pediatric cardiopulmonary bypass.
Modified ultrafiltration in pediatric cardiopulmonary bypass reduces total body water and serum levels of inflammatory mediators. It results in an elevated hematocrit without the need for transfusion, improved pulmonary compliance in the immediate postbypass period, and probably improved cerebral metabolic recovery after deep hypothermic circulatory arrest.
Modified ultrafiltration can be performed safely in neonatal patients after cardiopulmonary bypass and offers advantages in comparison with conventional ultrafiltration.
血液稀释是小儿体外循环中的一个突出问题。超滤是一种用于减少液体量和组织水肿并提高血细胞比容而无需使用血液制品的方法。与传统超滤相比,改良超滤可能具有优势。
本文综述了改良超滤技术及其在小儿体外循环中的应用、结果、并发症和安全性。
小儿体外循环中的改良超滤可减少全身水分和炎症介质的血清水平。它无需输血即可提高血细胞比容,在体外循环后即刻改善肺顺应性,并可能改善深低温停循环后的脑代谢恢复。
改良超滤可在小儿体外循环后的新生儿患者中安全进行,与传统超滤相比具有优势。